ArticleNPJ systems biology and applications2025
Mapping fusion-driven cell reprogramming through integrative single-cell computational frameworks.
Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cell fusion generates hybrid cells with unique traits. To understand the transcriptional and signaling alterations after fusion, we analyzed a published single-cell RNA-sequencing dataset of fused murine cardiomyocytes (mHL1) and mesenchymal stromal/stem cells (mMSC). Our analysis showed that fused cells exhibit a transcriptional trajectory suggesting a rapid change that stabilizes over time. We observed asymmetric plasticity. Initially, at Day 1, fusion hybrids resembled mMSCs (mesenchymal reprogramming), but by Day 3, their gene expression shifted to resemble mHL1 cells (myogenic reprogramming). Our analysis also identified distinct transcriptional subpopulations, including a subset enriched for tenascin (extracellular matrix remodeling), accompanied by dynamic changes in cell adhesion and intercellular communication. We also saw a significant shift in signaling pathways over time. At Day 1, Wnt and Melanogenesis (regenerative/antioxidant) signaling were downregulated. By Day 3, stress resistance and cellular adaptation pathways became enriched. Gene regulatory network analysis revealed key changes in master regulators; genes associated with chromatin remodeling (Hmga2), circadian rhythm (Arntl), and mesenchymal identity (Prrx1) became more active by Day 3. Collectively, our findings demonstrate that cell fusion is a dynamic reprogramming process, where evolving gene regulatory and signaling networks generate novel hybrid cell states, creating cellular diversity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.